| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Bienaime Jean Jacques serves as a Director at BMRN and has filed Form 4s across 6 companies. Across recent SEC filings that breaks down to 32 buys and 186 sells. Those positions are worth an estimated $38.3M at current prices.
Historically, Bienaime Jean Jacques's trades have earned a middling insider score of 68/100 across 67 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +8.5%.
The biggest single holding is BMRN (~$36.5M) as Director. The recent filings there lean toward selling, a net 2,115,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | BMRN Biomarin Pharmaceutical Inc | Director | Sell | 2,000 | $86.11 | $172,223.00 | -0.4% | -8.9% | -17.9% | |
| Feb 27, 2024 | BMRN Biomarin Pharmaceutical Inc | Director | Sell | 1,000 | $90.35 | $90,350.00 | -0.2% | -17.9% | -24.1% | |
| Feb 9, 2024 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE10b5-1 | 30,000 | $89.03 | $2,670,750.00 | -6.7% | -7.6% | -27.7% | |
| Jan 10, 2024 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE10b5-1 | 20,000 | $97.29 | $1,945,700.00 | -4.5% | -7.2% | -29.7% | |
| Dec 21, 2023 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE10b5-1 | 10,000 | $93.99 | $939,900.00 | -2.3% | -10.9% | -31.0% | |
| Aug 8, 2023 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sell | 10,000 | $88.21 | $882,140.00 | -2.3% | -15.9% | -4.8% | |
| May 11, 2023 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE10b5-1 | 30,000 | $94.67 | $2,840,225.87 | -6.6% | -2.3% | -15.1% | |
| May 10, 2023 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE10b5-1 | 60,000 | $94.89 | $5,693,370.51 | -12.3% | -4.8% | -14.1% | |
| Apr 10, 2023 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE10b5-1 | 10,000 | $99.56 | $995,600.00 | -2.3% | -12.8% | -9.3% | |
| Apr 6, 2023 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE10b5-1 | 10,000 | $96.13 | $961,300.00 | -2.3% | -12.4% | -12.7% |